Literature DB >> 17879378

N-methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet.

Kenneth C Waterman1, William B Arikpo, Michael B Fergione, Timothy W Graul, Barbara A Johnson, Bruce C Macdonald, Michael C Roy, Robert J Timpano.   

Abstract

Significant degradation of the amine-based smoking cessation drug varenicline tartrate in an early development phase osmotic, controlled-release (CR) formulation yields predominantly two products: N-methylvarenicline (NMV) and N-formylvarenicline (NFV). NMV is produced by reaction of the amine moiety with both formaldehyde and formic acid in an Eschweiler-Clarke reaction, while NFV is formed by reaction of formic acid alone with varenicline. This represents the first report of these reactions occurring on storage of solid pharmaceutical formulations. Both formaldehyde and formic acid are formed from oxidative degradation of polyethylene glycol (PEG) used in an osmotic coating through a process heavily dependent on the physical state of the PEG. When the concentration of PEG in the coating is sufficiently low, the PEG remains phase compatible with the other component of the coating (cellulose acetate) such that its degradation (and the resulting drug reactivity) is effectively eliminated. Antioxidants in the coating and oxygen scavengers in the packaging also serve to prevent the PEG degradation, and consequently provide for drug stability. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17879378     DOI: 10.1002/jps.21119

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

Review 1.  Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.

Authors:  Yongmei Wu; Jaquan Levons; Ajit S Narang; Krishnaswamy Raghavan; Venkatramana M Rao
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

Review 2.  Impact of excipient interactions on solid dosage form stability.

Authors:  Ajit S Narang; Divyakant Desai; Sherif Badawy
Journal:  Pharm Res       Date:  2012-06-16       Impact factor: 4.200

3.  Stability of benzocaine formulated in commercial oral disintegrating tablet platforms.

Authors:  Melanie Köllmer; Carmen Popescu; Prashanth Manda; Leon Zhou; Richard A Gemeinhart
Journal:  AAPS PharmSciTech       Date:  2013-08-30       Impact factor: 3.246

4.  Chemical drug stability in lipids, modified lipids, and polyethylene oxide-containing formulations.

Authors:  Valentino J Stella
Journal:  Pharm Res       Date:  2013-05-02       Impact factor: 4.200

5.  A Robust Static Headspace GC-FID Method to Detect and Quantify Formaldehyde Impurity in Pharmaceutical Excipients.

Authors:  Bashir Daoud Agha Dit Daoudy; Mohammad Ammar Al-Khayat; Francois Karabet; Mohammad Amer Al-Mardini
Journal:  J Anal Methods Chem       Date:  2018-03-04       Impact factor: 2.193

6.  Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin.

Authors:  Blaž Robnik; Blaž Likozar; Baifan Wang; Tijana Stanić Ljubin; Zdenko Časar
Journal:  Pharmaceutics       Date:  2019-09-02       Impact factor: 6.321

7.  A Novel Testing Approach for Oxidative Degradation Dependent Incompatibility of Amine Moiety Containing Drugs with PEGs in Solid-State.

Authors:  Blaž Robnik; Katerina Naumoska; Zdenko Časar
Journal:  Pharmaceutics       Date:  2020-01-02       Impact factor: 6.321

Review 8.  New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Authors:  Emma Beard; Lion Shahab; Damian M Cummings; Susan Michie; Robert West
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.